Suppr超能文献

2089名表面健康个体的微量白蛋白尿与全因死亡率:一项4.4年的随访研究。挪威北特伦德拉格郡健康研究(HUNT)

Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trøndelag Health Study (HUNT), Norway.

作者信息

Romundstad Solfrid, Holmen Jostein, Kvenild Kurt, Hallan Hans, Ellekjaer Hanne

机构信息

HUNT Research Center, Department of Public Health and General Practice, Norwegian University of Science and Technology, Verdal, Norway.

出版信息

Am J Kidney Dis. 2003 Sep;42(3):466-73. doi: 10.1016/s0272-6386(03)00742-x.

Abstract

BACKGROUND

To date, there are few large follow-up studies of apparently healthy subjects with microalbuminuria (MA). The aim of this study is to examine the association between MA and all-cause mortality in nondiabetic nonhypertensive individuals.

METHODS

We conducted a 4.4-year mortality follow-up of 2,089 men and women (> or =20 years) without diabetes and treated hypertension, randomly selected from the population-based Nord-Trøndelag Health Study (1995 to 1997; n = 65,258). Main outcome measures were adjusted relative risk (RR) for all-cause mortality according to increasing albuminuria, defined at different albumin-creatinine ratio (ACR) levels and in 1/2 or 3 urine samples. The main analysis was performed after exclusion of those with cardiovascular disease.

RESULTS

There was a positive association between all-cause mortality and MA. The lowest ACR level associated with increased RR for mortality was the 60th percentile (> or =6.7 microg/mg [0.76 mg/mmol]; RR, 2.4; 95% confidence interval, 1.1 to 5.2), applying 3 urine samples with an ACR greater than the cutoff level. We found a positive association between mortality and increasing numbers of urine samples with an ACR greater than different cutoff levels, in which 3 urine samples were superior. Results persisted after adjusting for several confounders and excluding individuals with untreated hypertension (systolic blood pressure > or = 140 mm Hg/diastolic blood pressure > or = 90 mm Hg) and those who died during the first year of follow-up.

CONCLUSION

Although this study confirms the association of all-cause mortality and ACR level in apparently healthy individuals, intervention trials are necessary before clinical cutoff levels of ACR are established and before screening programs are recommended.

摘要

背景

迄今为止,针对微量白蛋白尿(MA)的明显健康受试者的大型随访研究较少。本研究旨在探讨非糖尿病非高血压个体中MA与全因死亡率之间的关联。

方法

我们对从基于人群的北特伦德拉格健康研究(1995年至1997年;n = 65258)中随机选取的2089名年龄≥20岁、无糖尿病且未接受高血压治疗的男性和女性进行了4.4年的死亡率随访。主要结局指标是根据不同白蛋白肌酐比值(ACR)水平以及1/2或3份尿液样本中定义的蛋白尿增加情况调整后的全因死亡率相对风险(RR)。主要分析在排除心血管疾病患者后进行。

结果

全因死亡率与MA之间存在正相关。应用3份ACR大于临界值水平的尿液样本时,与死亡率RR增加相关的最低ACR水平为第60百分位数(≥6.7微克/毫克[0.76毫克/毫摩尔];RR,2.4;95%置信区间,1.1至5.2)。我们发现死亡率与ACR大于不同临界值水平的尿液样本数量增加之间存在正相关,其中3份尿液样本的相关性更佳。在调整了多个混杂因素并排除未治疗高血压患者(收缩压≥140毫米汞柱/舒张压≥90毫米汞柱)以及随访第一年死亡的个体后,结果依然成立。

结论

尽管本研究证实了明显健康个体中全因死亡率与ACR水平之间的关联,但在确定ACR的临床临界值水平以及推荐筛查项目之前,仍需要进行干预试验。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验